The table below shows Nuvation Bio Inc.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Revenue
$62.90M
$7.87M
-
-
-
-
Cost of revenue
-
$7.08M
$0.00
-
-
-
Gross profit
-
$795.00K
$0.00
-
-
-
R&D
$115.11M
$99.12M
$71.29M
$87.81M
$69.04M
$32.60M
SG&A
$151.56M
NUVB annual revenue (10-K history)
Nuvation Bio Inc. reported annual revenue of $62.90M for fiscal year 2025. That is up 699.0% from $7.87M in fiscal 2024. Figures come from the company's audited annual reports as filed with the SEC.